Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Outcome of Inactive HBsAg Carrier Patients With Low HBV DNA Levels and Normal ALT by Antiviral Therapy

NCT05357235 is registered in ClinicalTrials.gov with Beijing Ditan Hospital as lead sponsor.

NCT NCT05357235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05357235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Outcome of Inactive HBsAg Carrier Patients With Low HBV DNA Levels and Normal ALT by Antiviral Therapy
Lead sponsor
Beijing Ditan Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2022
Completion date
December 31, 2024
Enrollment
1,200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis b